Response to McGurk et al
- PMID: 34906521
- DOI: 10.1016/j.gim.2021.10.021
Response to McGurk et al
Conflict of interest statement
Conflict of Interest D.T.M. has received honoraria from Ambry Genetics and Prevention Genetics LLC. S.M.H is an employee of Ambry Genetics. All other authors declare no conflicts of interest.
Comment on
-
ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).Genet Med. 2021 Aug;23(8):1381-1390. doi: 10.1038/s41436-021-01172-3. Epub 2021 May 20. Genet Med. 2021. PMID: 34012068 No abstract available.
-
Correspondence on "ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)" by Miller et al.Genet Med. 2022 Mar;24(3):744-746. doi: 10.1016/j.gim.2021.10.020. Epub 2021 Nov 30. Genet Med. 2022. PMID: 34906520 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources
